Latest filing published 10 Dec 2009 for Alaunos Therapeutics, Inc., €409k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +48.7%Entry US$456.00 · Close at T+365 US$678.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Essex Woodlands Health Ventures Fund VI L P: trading record in brief
Essex Woodlands Health Ventures Fund VI L P is a declared insider at 3 companies; the most frequent names are La Jolla Pharmaceutical Co, Alaunos Therapeutics, Inc. and Bioform Medical Inc. Between 22 February 2007 and 8 December 2009, the trades on record add up to 11 filings.
Market trades split into 4 purchases (€7.7M) and 5 sales (€556k). Taken together, the purchases exceed the sales by €7.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. In 2009 alone, the filings show 2 purchases and 5 sales.
The median purchase comes to €1.5M.
Most recently, on 10 December 2009, the filings show an open-market purchase worth €409k in Alaunos Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Essex Woodlands Health Ventures Fund VI L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 328,766 shares@ US$1.83Common StockSEC:0001181431-09-056034:0Canonical exit: 14 Dec 2009 (T+90)
- 129,000 shares@ US$3.10Common StockSEC:0001181431-09-056034:1Canonical exit: 8 Mar 2010 (T+90)
- 792,942 shares@ US$0.1872Common StockSEC:0001181431-09-038509:0
- 368,872 shares@ US$0.1833Common StockSEC:0001181431-09-038509:1
- 2,164,033 shares@ US$0.0739Common StockSEC:0001181431-09-011842:0
- 2,186,211 shares@ US$0.0635Common StockSEC:0001181431-09-011842:1
- 4,236,586 shares@ US$0.0516Common StockSEC:0001181431-09-011842:2
- 7,087,295 sharesCommon StockSEC:0001181431-07-069306:0
- 1,913,876 shares@ US$5.23Common StockSEC:0001181431-07-014007:0
9 of 9 declarations
